Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 23 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Allopurinol | 1件: Allopurinol Allopurinol | 1件: Allopurinol
Allopurinol
💬1. Allopurinol
| 1件: XDH XDH 💬1. Allopurinol
| 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, ... | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
| ||||||||||||||||||||||||||||||||||||||||
| 2 | Benazepril | 1件: Benazepril Benazepril | 1件: Benazepril
Benazepril
💬2. Benazepril
| 1件: ACE ACE 💬2. Benazepril
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyop ... | 4件: 49 49, 57, 218, 224 💬
| ||||||||||||||||||||||||||||||||||||||||
| 3 | Carvedilol | 1件: Carvedilol Carvedilol | 1件: Carvedilol
Carvedilol
💬3. Carvedilol
| 5件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 4件: 57 57, 86, 113, 210 💬
| ||||||||||||||||||||||||||||||||||||||||
| 4 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬4. Coenzyme Q10
| - | - | 11件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬4. Coenzyme Q10
| ||||||||||||||||||||||||||||||||||||||||
| 5 | Dobutamine | 1件: Dobutamine Dobutamine | 1件: Dobutamine
Dobutamine
💬5. Dobutamine
| 1件: ADRB1 ADRB1 💬5. Dobutamine
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - re ... | 4件: 57 57, 58, 86, 215 💬
| ||||||||||||||||||||||||||||||||||||||||
| 6 | Doxazosin | 1件: Doxazosin Doxazosin | 1件: Doxazosin
Doxazosin
💬6. Doxazosin
| 3件: ADRA1A ADRA1A,ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuro ... | 2件: 57 57, 67 💬
| ||||||||||||||||||||||||||||||||||||||||
| 7 | Granocyte | - | - | - | - | 2件: 18 18, 57 💬
| ||||||||||||||||||||||||||||||||||||||||
| 8 | GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF) | 1件: Lenograstim Lenograstim | 1件: Lenograstim
Lenograstim
💬8. GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)
| 1件: CSF3R CSF3R 💬8. GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 57 57 💬8. GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)
| ||||||||||||||||||||||||||||||||||||||||
| 9 | Granocyte Lenograstim | 1件: Lenograstim Lenograstim | 1件: Lenograstim
Lenograstim
💬9. Granocyte Lenograstim
| 1件: CSF3R CSF3R 💬9. Granocyte Lenograstim
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 57 57 💬9. Granocyte Lenograstim
| ||||||||||||||||||||||||||||||||||||||||
| 10 | Granulocyte Colony Stimulating Factor | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬10. Granulocyte Colony Stimulating Factor
| 1件: CSF3R CSF3R 💬10. Granulocyte Colony Stimulating Factor
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 6件: 2 2, 28, 36, 57, 65, 85 💬
|